Metraipolis › archive › dc_fe4866e44699

Omalizumab Therapy Results in Defined Behavioural Changes and Improvements in Quality of Life in Solar Urticaria — Europe PMC PMID:41962134

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41962134
DOI
10.1111/phpp.70088
License (as archived)
solo-consultazione
Archived
2026-11-02T22:24:52.730Z
SHA-256 of the archived text
23ca171b1ebce41a7e8539542591a868af34272ab68cc75d384ec924adc8b81d
Stable URL of this page
https://metraipolis.com/documento/dc_fe4866e44699

How to cite

Omalizumab Therapy Results in Defined Behavioural Changes and Improvements in Quality of Life in Solar Urticaria — Europe PMC PMID:41962134 — Europe PMC (en), https://europepmc.org/article/MED/41962134 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fe4866e44699 (Metraipolis archive dc_fe4866e44699, sha256 23ca171b1ebce41a7e8539542591a868af34272ab68cc75d384ec924adc8b81d)
BibTeX
@misc{dcfe4866e44699,
  title = {Omalizumab Therapy Results in Defined Behavioural Changes and Improvements in Quality of Life in Solar Urticaria — Europe PMC PMID:41962134},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41962134},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fe4866e44699; sha256 23ca171b1ebce41a7e8539542591a868af34272ab68cc75d384ec924adc8b81d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41962134. Agents can read the archived copy with the MCP tool read_document.